Developments to Income Access Share Arrangements - Elections for the Interim Dividend in Respect of the Six Months to December 31, 2015

Dublin (ots/PRNewswire) -

Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") reminds
shareholders of important developments relating to the Company's
Income Access Share arrangements ("IAS Arrangements").

All shareholders who wish to receive, or continue to receive, UK
sourced dividends via the IAS Arrangements (and therefore without
incurring Irish dividend withholding tax) need to complete the newly
formatted IAS Arrangements election forms and return to the address
stated therein.

Internet links to these forms, which were posted to shareholders
on February 16, 2016, can be found on the Company's website:

http://investors.shire.com/shareholder-information/shareholder-for
ms.aspx

In order for submitted IAS Arrangements election forms to be valid
in respect of the dividend to be paid on April 12, 2016, they need to
be received by the Company's Registrar, Equiniti, by 5pm (UK time) on
March 11, 2016. Election forms received after this date will not be
applied to this dividend though will be applied to future dividend
payments.

Shareholders who do not elect to receive UK sourced dividends
using the new IAS Arrangements election forms are advised that their
dividends will be Irish sourced and therefore incur Irish dividend
withholding tax, subject to applicable exemptions. A letter advising
of the above information has today been posted to shareholders with a
corresponding internet link made available on the Company's website:
http://www.shire.com. In accordance with Listing Rule 9.6.1R, the
letter has also been uploaded to the National Storage Mechanism and
will be available for viewing shortly. If you are in any doubt as to
what action to take, please consult your tax advisor immediately.

For further information concerning the IAS Arrangements or Irish
dividend withholding tax exemptions, please contact Equiniti
(+44-(0)121-415 7593).

Oliver Strawbridge Senior Assistant Company Secretary

NOTES TO EDITORS

The Company operates IAS Arrangements. Shareholders who elect to
receive the Company's dividends via the IAS Arrangements receive such
dividends from a subsidiary of the Company that is tax resident in
the UK. Dividends paid under the IAS Arrangements are not, under
current legislation, subject to any UK or Irish withholding taxes.
Dividends paid outside of the IAS Arrangements are subject to Irish
dividend withholding tax at a rate of 20%, or such lower rate as may
be applicable under exemptions from withholding tax contained in
Irish law.

Shareholders are advised that recent developments in global tax
law, namely the introduction of the Foreign Account Tax Compliance
Act and the Common Reporting Standard, have introduced new reporting
obligations relating to the IAS Arrangements. These require that
certain information relating to shareholders participating in the IAS
Arrangements is reported to the appropriate tax authorities. In order
to ensure the new reporting obligations are met, the Company is
requesting from electing (or deemed electing) shareholders the
relevant information via new IAS Arrangements election forms (and
continuation forms in respect of joint holders). The availability of
these forms is outlined in the announcement above.

Shire enables people with life-altering conditions to lead better
lives.

Our strategy is to focus on developing and marketing innovative
specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience,
Gastrointestinal and Internal Medicine and we are developing
treatments for symptomatic conditions treated by specialist
physicians in other targeted therapeutic areas, such as Ophthalmics.

http://www.shire.com

ots Originaltext: Shire Pharmaceuticals Group Plc
Im Internet recherchierbar: http://www.presseportal.de

Contact:
please contact:
Investor Relations
Sarah Elton-Farr
seltonfarr@shire.com
+44-1256-894157